Cinnamon and COH in PCOS Women Underdoing IVF/ICSI Cycles
Conditions: Polycystic Ovary Syndrome Interventions: Dietary Supplement: Oral cinnamon supplementation Sponsors: Royan Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials

Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome
Conditions: Comparative Study Interventions: Drug: Metformin Sponsors: Hamdard University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials

The Phenotype and Clinical Intervention of High BCAA Type of PCOS
Conditions: Polycystic Ovary Syndrome Interventions: Dietary Supplement: protein restricted diet combined with vitamin D intervention Sponsors: Peking University Third Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization
Conditions: IVF Interventions: Procedure: Controlled Ovarian Stimulation Protocol Sponsors: Hanoi Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

Machine Learning Predicts Survival and Mutations in Ovarian Metastases of Colorectal Cancer
Conditions: Ovarian Metastases of Colorectal Cancer Interventions: Other: Prediction model Sponsors: Sixth Affiliated Hospital, Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

Effect of Web-Based Module on Nursing Students' Knowledge, Practice and Attitude Regarding Polycystic Ovary Syndrome
Conditions: PCOS Interventions: Other: Web-Based Learning Module (WBL) Sponsors: Safa Hamdy Alkalash Alsayed; Mansoura University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
Conditions: ER+ HER2- Advanced Breast Cancer; High-grade Serous Ovarian Cancer (HGSOC) Interventions: Drug: AZD8421; Drug: Camizestrant; Drug: Ribociclib; Drug: Palbociclib; Drug: Abemaciclib Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Drug: Fluzoparib Capsules; Drug: Apatinib Mesylate Tablets Sponsors: The First Affiliated Hospital of Xiamen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials

A randomized, controlled clinical study of low-molecular-weight heparin improving pregnancy outcomes in PCOS women undergoing IVF: study protocol
The objective of this study is to investigate the effect of LMWH on pregnancy outcomes after invitro fertilization-frozen embryo transfer (IVF-FET) in patients with polycystic ovary syndrome.MethodsA total of 356 PCOS women aged between 20 and 38 years which prepared for IVF followed with FET will be enrolled in the study. The patients, from four different hospitals stratified by age and body mass index (BMI), will be randomly divided into the study group who will be treated with LMWH started on the day of progesterone transformation (hormone therapy) during FET cycle and the control group without additional medicine. Seru...
Source: Trials - January 2, 2024 Category: Research Source Type: clinical trials

Periodontal Status and Endothelial Dysfunction in Patients With Polycystic Ovary Syndrome
Conditions: Periodontal Diseases Sponsors: Fundaci ón para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana; Instituto de Salud Carlos III Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials

Choices About Genetic Testing And Learning Your Risk With Smart Technology
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer; Pancreas Cancer; Colorectal Cancer; Endometrial Cancer; Prostate Cancer Interventions: Device: Relational Agent; Other: Clinical Letter Sponsors: Rutgers, The State University of New Jersey Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients
Conditions: Ovarian Cancer Sponsors: West China Second University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
Conditions: Ovarian Cancer; Oligometastatic Disease; Serous Ovarian Tumor Interventions: Drug: Niraparib oral tablets Sponsors: MedSIR Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials

Effect of transvaginal Lactobacillus supplementation on reversing lower genital tract dysbiosis and improving perinatal outcomes in PCOS patients after IVF-FET: a study protocol for a multicenter randomized controlled trial
DiscussionThis is the first large and multicenter randomized controlled trial aimed at assessing the efficacy of transvaginalLactobacillus supplementation on restoring the LGT microbiome and improving perinatal outcomes in PCOS patients after IVF-FET. This pragmatic trial is promising for increasing the rates of clinical pregnancy and live birth in PCOS patients after IVF-FET.Ethics and disseminationEthical review approval was obtained from the Medical Research Ethics Committees of the International Peace Maternity and Child Health Hospital of Shanghai Jiao Tong University (15 October 2020, GKLW 2020-29). To maximize disse...
Source: Trials - December 21, 2023 Category: Research Source Type: clinical trials

PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
Conditions: Ovarian Stimulation; Quality of Life; Preimplantation Genetic Testing; Fertility Preservation Interventions: Drug: Elonva ®; Drug: Puregon®; Drug: Orgalutran®; Drug: Gonapeptyl®; Drug: Cerazette® Sponsors: University Hospital, Ghent Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials